What is the appropriate treatment and management for dengue infection?

Dengue Treatment

For uncomplicated dengue fever, treatment is supportive with oral hydration, antipyretics (paracetamol only—avoid NSAIDs and aspirin), and close monitoring for warning signs; for dengue shock syndrome, initiate immediate fluid resuscitation with crystalloids at 20 mL/kg bolus, with colloids reserved only for severe or refractory shock. 1

Clinical Staging and Risk Stratification

Dengue presents in three distinct phases that dictate management:

• Febrile phase (days 1-7): High fever, headache, retro-orbital pain, myalgia, arthralgia (especially back pain), and rash 2
• Critical phase (days 3-7): Plasma leakage, thrombocytopenia, warning signs emerge
• Recovery phase: Fluid reabsorption, clinical improvement

Warning signs requiring hospitalization include: abdominal pain, persistent vomiting, clinical fluid accumulation (ascites, pleural effusion), mucosal bleeding, lethargy/restlessness, liver enlargement >2 cm, and rising hematocrit with rapid platelet decline 3.

Diagnostic Approach

Early diagnosis (≤5 days of symptoms): PCR or NS1 antigen detection in serum 2, 4

Later diagnosis (≥5-7 days): IgM capture ELISA 2, 4

Convalescent confirmation: IgG ELISA at 3 weeks 2

Note that cross-reactivity with other flaviviruses (yellow fever, Japanese encephalitis, Zika) occurs, so document vaccination history 2, 4.

Fluid Management Algorithm

For Patients WITHOUT Warning Signs (Outpatient Management)

• Oral rehydration with water, oral rehydration solution, or fruit juices
• Paracetamol for fever (avoid NSAIDs and aspirin due to bleeding risk)
• Daily monitoring for warning signs
• No prophylactic platelet transfusion 3, 5

For Patients WITH Warning Signs or Plasma Leakage (Hospitalization Required)

Initial resuscitation 1, 3:

• Crystalloids first-line: 20 mL/kg bolus over 15-30 minutes (lactated Ringer's or normal saline)
• Reassess after each bolus for clinical improvement (capillary refill, peripheral pulses, mental status, urine output ≥0.5 mL/kg/hour)
• Repeat crystalloid boluses as needed based on clinical response

For severe or refractory dengue shock syndrome 6, 1:

• Consider colloids (dextran or other colloids) if shock persists despite adequate crystalloid resuscitation
• Moderate-quality evidence shows colloids may benefit severe dengue shock (pulse pressure <10 mmHg) 1
• However, crystalloids remain first-line in most cases due to cost, allergy risk, and potential renal/coagulation effects 6

Critical caveat: Dengue shock behaves differently from bacterial septic shock. The 2015 International Consensus specifically recommends against routine bolus IV fluids for "severe febrile illness" without shock, as one large pediatric trial showed harm (RR 0.76) 1. This contrasts with bacterial sepsis management.

Fluid Deresuscitation

Once the critical phase passes (typically 24-48 hours after defervescence), actively reduce IV fluids to prevent fluid overload complications 7. Monitor for:

• Declining hematocrit
• Improving platelet count
• Resolution of plasma leakage
• Adequate urine output

Vasopressor Support

If tissue hypoperfusion persists despite liberal fluid resuscitation 6:

• Dopamine or epinephrine (adrenaline) are recommended
• Preferentially use central venous access; if unavailable, large-bore peripheral IV or intraosseous access acceptable
• Monitor infusion site frequently for extravasation and skin necrosis
• Keep doses minimal due to dose-dependent adverse effects

Transfusion Management

Platelet transfusion 8, 3, 5:

• NOT indicated prophylactically for thrombocytopenia alone
• Consider only for active bleeding with severe thrombocytopenia or before invasive procedures
• No standardized threshold exists; clinical judgment based on bleeding risk

Monitoring Parameters

Clinical indicators of adequate perfusion 6:

• Normal capillary refill time (<2-3 seconds in adults, <4.5 seconds in elderly)
• Absence of skin mottling
• Warm, dry extremities
• Well-palpable peripheral pulses
• Return to baseline mental status
• Urine output ≥0.5 mL/kg/hour (adults) or ≥1 mL/kg/hour (children)

Laboratory monitoring: Serial hematocrit (rising indicates hemoconcentration/plasma leakage), platelet count, liver enzymes, coagulation studies if bleeding present 8, 3.

Common Pitfalls

1. Avoid NSAIDs and aspirin: Increase bleeding risk due to antiplatelet effects and potential for Reye's syndrome
2. Avoid excessive fluid administration: Can cause pulmonary edema and pleural effusions, particularly during recovery phase 7
3. Don't apply bacterial sepsis protocols blindly: Dengue shock requires more judicious fluid management 1
4. Cardiac complications are underdiagnosed: Myocarditis, pericarditis, and arrhythmias occur in 12-50% of hospitalized patients; consider echocardiography if cardiac symptoms present 9

Special Populations

Pregnant women: Zika virus RNA may persist longer; consider extended testing window 4

Children: May have higher incidence of cardiac complications; lower threshold for cardiac evaluation 9

Severe dengue with organ involvement: Dengue hemorrhagic fever and dengue shock syndrome are rare in travelers but require intensive care with aggressive supportive management 2

Prevention Context

While not treatment per se, the Dengvaxia vaccine exists but has complex indications due to antibody-dependent enhancement risk in seronegative individuals 5. Vector control with Wolbachia-infected mosquitoes shows effectiveness 8.